A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer
Nicholas C. D’Amato(Vaxart (United States)), Jennifer K. Richer(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Dawn R. Cochrane(BC Cancer Agency), Nicole S. Spoelstra(University of Colorado Anschutz Medical Campus), Melita A. Gordon(University of Liverpool), Thomas J. Rogers(Van Andel Institute), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Lisa I. Greene(University of Colorado Anschutz Medical Campus), Travis Nemkov(University of Colorado Anschutz Medical Campus)
Cited by 303
Related Papers
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
|Journal of Biological Chemistry|2002|574
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556